EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Designing Antitrypanosomal and Antileishmanial BODIPY Derivatives: A Computational and In Vitro Assessment

Raquel C R Gonçalves, Filipe Teixeira iD, Pablo Peñalver iD, Susana P G Costa iD, Juan C Morales iD, M Manuela M Raposo iD

Molecules · 2024

DOI: 10.3390/molecules29092072 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecules, 2024. Verfasst von Raquel C R Gonçalves und 5 weiteren Autor:innen. Beteiligte Einrichtung: Centre of Chemistry, University of Minho, Campus de Gualtar, 4710-057 Braga, Portugal. Hauptthemen laut MEDLINE: Boron Compounds, Trypanosoma brucei brucei, Molecular Docking Simulation, Antiprotozoal Agents. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fundação para a Ciência e Tecnologia (FCT) and FEDER (European Fund for Regional Development)-COMPETE-QRENEU, PhD, POCI 2010 (FEDER) and FCT.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Leishmaniasis and Human African trypanosomiasis pose significant public health threats in resource-limited regions, accentuated by the drawbacks of the current antiprotozoal treatments and the lack of approved vaccines. Considering the demand for novel therapeutic drugs, a series of BODIPY derivatives with several functionalizations at the meso, 2 and/or 6 positions of the core were synthesized and characterized. The in vitro activity against Trypanosoma brucei and Leishmania major parasites was carried out alongside a human healthy cell line (MRC-5) to establish selectivity indices (SIs). Notably, the meso-substituted BODIPY, with 1-dimethylaminonaphthalene (1b) and anthracene moiety (1c), were the most active against L. major, displaying IC50 = 4.84 and 5.41 μM, with a 16 and 18-fold selectivity over MRC-5 cells, respectively. In contrast, the mono-formylated analogues 2b and 2c exhibited the highest toxicity (IC50 = 2.84 and 6.17 μM, respectively) and selectivity (SI = 24 and 11, respectively) against T. brucei. Further insights on the activity of these compounds were gathered from molecular docking studies. The results suggest that these BODIPYs act as competitive inhibitors targeting the NADPH/NADP+ linkage site of the pteridine reductase (PR) enzyme. Additionally, these findings unveil a range of quasi-degenerate binding complexes formed between the PRs and the investigated BODIPY derivatives. These results suggest a potential correlation between the anti-parasitic activity and the presence of multiple configurations that block the same site of the enzyme.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Boron CompoundsTrypanosoma brucei bruceiMolecular Docking SimulationAntiprotozoal AgentsLeishmania majorHumansDrug DesignStructure-Activity RelationshipCell LineMolecular StructureTrypanocidal AgentsOxidoreductases

Stichwörter der Autor:innen

BODIPY derivativesLeishmania majorTrypanosoma bruceiantiprotozoal agentmolecular modeling

Substanzen

Boron Compounds4,4-difluoro-4-bora-3a,4a-diaza-s-indaceneAntiprotozoal Agentspteridine reductaseTrypanocidal AgentsOxidoreductases

Autor:innen und Institutionen

  • Centre of Chemistry, University of Minho, Campus de Gualtar, 4710-057 Braga, Portugal.
  • Advanced (Magnetic) Theranostic Nanostructures Lab, International Iberian Nanotechnology Laboratory, Av. Mestre José Veiga s/n, 4715-330 Braga, Portugal.
  • Instituto de Parasitología y Biomedicina López Neyra, CSIC, PTS Granada, Avenida del Conocimiento, 17, 18016 Armilla, Granada, Spain.

ORCID-Profile: Filipe Teixeira, Pablo Peñalver, Susana P G Costa, Juan C Morales, M Manuela M Raposo

Förderung

  • Fundação para a Ciência e Tecnologia (FCT) and FEDER (European Fund for Regional Development)-COMPETE-QRENEU
  • PhD
  • POCI 2010 (FEDER) and FCT

Zitieren

APA

Gonçalves, R. C. R., Teixeira, F., Peñalver, P., Costa, S. P. G., Morales, J. C., & Raposo, M. M. M. (2024). Designing Antitrypanosomal and Antileishmanial BODIPY Derivatives: A Computational and In Vitro Assessment. Molecules. https://doi.org/10.3390/molecules29092072

Vancouver

Gonçalves RCR, Teixeira F, Peñalver P, Costa SPG, Morales JC, Raposo MMM. Designing Antitrypanosomal and Antileishmanial BODIPY Derivatives: A Computational and In Vitro Assessment. Molecules. 2024. doi:10.3390/molecules29092072

BibTeX
@article{Gonalves2024,
  author = {Gonçalves, Raquel C R and Teixeira, Filipe and Peñalver, Pablo and Costa, Susana P G and Morales, Juan C and Raposo, M Manuela M},
  title = {Designing Antitrypanosomal and Antileishmanial BODIPY Derivatives: A Computational and In Vitro Assessment},
  journal = {Molecules},
  year = {2024},
  doi = {10.3390/molecules29092072}
}
Kostenlos starten →